Interestingly, the downregulation of AIMP2-DX2 expression by shRNA suppressed the epidermal growth factor receptor (EGFR)/MAPK signaling pathway, thereby inhibiting glucose uptake and cancer cell growth95. The gene discussed is AIMP2; the disease is cancer.